Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income attributable to common stockholders	$ 3,286	$ 4,088	$ 3,693	$ 2,498	$ 3,662	$ 11,049	$ 9,366
Adjustments to reconcile net income to net cash provided by operating activities:
Net accretion on debt securities						(64)	(46)
Depreciation expense						1,644	1,787
(Negative provision) provision for credit losses	(400)					(2,725)	175
Net loss (gain) on equity securities						569	(170)
Net realized gain on sale of debt securities	0			0		0	(12)
Deferred tax asset valuation allowance				1,828		0	1,828
Increase in mortgage servicing rights resulting from transfers of financial assets						(258)	(138)
Mortgage servicing rights amortization and impairment, net						427	456
Amortization of intangible assets	178			179		536	576
Amortization of restricted stock						475	590
Decrease in deferred income taxes						284	226
Increase in cash surrender value of life insurance						(753)	(513)
Net gain from disposals of foreclosed and repossessed assets						(23)	62
Provision for valuation allowance on foreclosed properties						70	0
Gain on sale of loans held for sale, net						(1,998)	(1,501)
Proceeds from sale of loans held for sale						48,833	34,630
Originations of loans held for sale						(41,759)	(35,866)
Net change in:
Accrued interest receivable and other assets						(2,528)	(1,615)
Other liabilities						3,803	(663)
Total adjustments						6,533	(194)
Net cash provided by operating activities						17,582	9,172
Cash flows from investing activities:
Proceeds from Bank Owned Life Insurance (BOLI) death benefit						499	0
Net decrease in other interest bearing deposits						0	249
Purchase of available for sale securities						0	(11,007)
Proceeds from principal payments of available for sale securities						11,544	13,164
Proceeds from sales of available for sale securities	0			0		0	5,105
Proceeds from principal payments and maturities of held to maturity securities						4,184	4,031
Equity investment capital distribution						170	132
Purchase of equity investments						(300)	(600)
Net sales (purchases) of other investments						558	725
Proceeds from sales of foreclosed and repossessed assets						232	307
Proceeds from insurance claim on foreclosed and repossessed assets						27	0
Net decrease (increase) in loans						36,702	(35,606)
Net capital expenditures						(649)	(771)
Proceeds from disposal of office properties and equipment						13	12
Net cash provided by (used in) investing activities						52,980	(24,259)
Cash flows from financing activities:
Change in short term Federal Home Loan Bank advances, net						(33,000)	15,000
Federal Home Loan Bank advance repayment due to FHLB call						(10,000)	0
Federal Home Loan Bank advance long-term maturities						(15,530)	(43,000)
Amortization of debt issuance costs						166	165
Other borrowings principal reductions						(6,083)	(5,167)
Net increase in deposits						1,571	48,515
Restricted common stock awarded under the equity incentive plan						0	1
Repurchase shares of common stock						(4,727)	(117)
Surrender of restricted shares of common stock						(119)	(129)
Common stock options exercised						0	28	$ 28
Cash dividends paid						(3,346)	(3,040)
Net cash (used in) provided by financing activities						(71,068)	12,256
Net decrease in cash and cash equivalents						(506)	(2,831)
Cash and cash equivalents at beginning of period		$ 37,138	32,532		$ 35,363	37,138	35,363	35,363
Cash and cash equivalents at end of period	$ 36,632		$ 37,138	$ 32,532		36,632	32,532	$ 37,138
Cash paid during the period for:
Interest on deposits						24,340	16,602
Interest on borrowings						3,924	8,363
Income taxes						2,064	3,855
Supplemental noncash disclosure:
Transfers from loans receivable to other real estate owned ("OREO")						$ 73	$ 144